Cecilie Ammitzbøll

622 total citations
19 papers, 438 citations indexed

About

Cecilie Ammitzbøll is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Cecilie Ammitzbøll has authored 19 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 9 papers in Immunology and 4 papers in Neurology. Recurrent topics in Cecilie Ammitzbøll's work include Multiple Sclerosis Research Studies (14 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). Cecilie Ammitzbøll is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). Cecilie Ammitzbøll collaborates with scholars based in Denmark. Cecilie Ammitzbøll's co-authors include Finn Sellebjerg, Marina Rode von Essen, Lars Börnsen, Jeppe Romme Christensen, R. Hansen, Eva Rosa Petersen, Rikke Ratzer, Per Soelberg Sørensen, Jørgen E. Nielsen and Lena E. Hjermind and has published in prestigious journals such as Brain, Annals of Neurology and Journal of Leukocyte Biology.

In The Last Decade

Cecilie Ammitzbøll

19 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilie Ammitzbøll Denmark 12 227 142 126 96 64 19 438
Miriam Tamaño‐Blanco United States 13 351 1.5× 91 0.6× 73 0.6× 126 1.3× 86 1.3× 21 534
Dieter Haering Switzerland 5 304 1.3× 37 0.3× 171 1.4× 101 1.1× 44 0.7× 11 459
John Soltys United States 9 203 0.9× 114 0.8× 183 1.5× 69 0.7× 27 0.4× 18 393
M. Starck Germany 8 298 1.3× 103 0.7× 94 0.7× 72 0.8× 23 0.4× 16 448
Giordani Rodrigues dos Passos Brazil 9 262 1.2× 79 0.6× 167 1.3× 56 0.6× 18 0.3× 17 377
Karim L. Kreft Netherlands 13 151 0.7× 141 1.0× 52 0.4× 104 1.1× 20 0.3× 24 408
Sam Loveless United Kingdom 8 207 0.9× 178 1.3× 81 0.6× 89 0.9× 23 0.4× 10 406
Patrick Peschl Austria 7 324 1.4× 75 0.5× 316 2.5× 80 0.8× 36 0.6× 10 496
Alessandra Mattioda Italy 6 295 1.3× 55 0.4× 126 1.0× 58 0.6× 18 0.3× 6 392
De‐Hyung Lee Germany 9 104 0.5× 48 0.3× 103 0.8× 65 0.7× 60 0.9× 12 304

Countries citing papers authored by Cecilie Ammitzbøll

Since Specialization
Citations

This map shows the geographic impact of Cecilie Ammitzbøll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilie Ammitzbøll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilie Ammitzbøll more than expected).

Fields of papers citing papers by Cecilie Ammitzbøll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilie Ammitzbøll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilie Ammitzbøll. The network helps show where Cecilie Ammitzbøll may publish in the future.

Co-authorship network of co-authors of Cecilie Ammitzbøll

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilie Ammitzbøll. A scholar is included among the top collaborators of Cecilie Ammitzbøll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilie Ammitzbøll. Cecilie Ammitzbøll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Søndergaard, Helle Bach, Anna Olsson, Stefan Gustavsen, et al.. (2024). Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis. Multiple Sclerosis and Related Disorders. 92. 106166–106166. 5 indexed citations
2.
Ammitzbøll, Cecilie, Tim B. Dyrby, Lars Börnsen, et al.. (2023). NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 77. 104854–104854. 5 indexed citations
3.
Essen, Marina Rode von, et al.. (2022). Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 9(4). 27 indexed citations
4.
Liu, Yawei, Jeppe Romme Christensen, Cecilie Ammitzbøll, et al.. (2021). Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 8(6). 4 indexed citations
5.
Essen, Marina Rode von, Cecilie Ammitzbøll, Lars Börnsen, & Finn Sellebjerg. (2021). Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosis. Clinical Immunology. 230. 108817–108817. 4 indexed citations
6.
Søndergaard, Helle Bach, et al.. (2021). Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 54. 103140–103140. 5 indexed citations
7.
Ammitzbøll, Cecilie, et al.. (2021). Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis. Multiple Sclerosis and Related Disorders. 52. 102987–102987. 16 indexed citations
8.
Ammitzbøll, Cecilie, Lars Börnsen, Eva Rosa Petersen, et al.. (2019). Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. Journal of Neuroimmunology. 330. 90–95. 12 indexed citations
9.
Petersen, Eva Rosa, Cecilie Ammitzbøll, Helle Bach Søndergaard, et al.. (2019). Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis. Journal of Neuroimmunology. 337. 577085–577085. 8 indexed citations
10.
Ammitzbøll, Cecilie, et al.. (2019). MAIT cell subtypes in multiple sclerosis. Journal of Neuroimmunology. 339. 577117–577117. 11 indexed citations
11.
Essen, Marina Rode von, Tua Vinther‐Jensen, Cecilie Ammitzbøll, et al.. (2019). Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease. Annals of Neurology. 87(2). 246–255. 30 indexed citations
12.
Essen, Marina Rode von, Cecilie Ammitzbøll, R. Hansen, et al.. (2018). Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis. Brain. 142(1). 120–132. 90 indexed citations
13.
Ammitzbøll, Cecilie, Marina Rode von Essen, Lars Börnsen, et al.. (2018). GPR15+ T cells are Th17 like, increased in smokers and associated with multiple sclerosis. Journal of Autoimmunity. 97. 114–121. 25 indexed citations
14.
Schreiber, Karen, Melinda Magyari, Cecilie Ammitzbøll, et al.. (2018). Progressive multiple sclerosis, cognitive function, and quality of life. Brain and Behavior. 8(2). e00875–e00875. 59 indexed citations
15.
Ammitzbøll, Cecilie, Tim B. Dyrby, Karen Schreiber, et al.. (2017). Disability in progressive MS is associated with T2 lesion changes. Multiple Sclerosis and Related Disorders. 20. 73–77. 7 indexed citations
16.
Sellebjerg, Finn, Lars Börnsen, Cecilie Ammitzbøll, et al.. (2017). Defining active progressive multiple sclerosis. Multiple Sclerosis Journal. 23(13). 1727–1735. 44 indexed citations
17.
Ammitzbøll, Cecilie, Lars Börnsen, Jeppe Romme Christensen, et al.. (2017). Smoking reduces circulating CD26hiCD161hi MAIT cells in healthy individuals and patients with multiple sclerosis. Journal of Leukocyte Biology. 101(5). 1211–1220. 17 indexed citations
18.
Vinther‐Jensen, Tua, Lars Börnsen, Esben Budtz–Jørgensen, et al.. (2016). Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease. Neurology Neuroimmunology & Neuroinflammation. 3(6). e287–e287. 44 indexed citations
19.
Ratzer, Rikke, Pernille Iversen, Lars Börnsen, et al.. (2015). Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis. Multiple Sclerosis Journal. 22(7). 926–934. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Tamaño‐Blanco Breakdown of academic impact, for papers by Dieter Haering Breakdown of academic impact, for papers by John Soltys Breakdown of academic impact, for papers by M. Starck Breakdown of academic impact, for papers by Giordani Rodrigues dos Passos Breakdown of academic impact, for papers by Karim L. Kreft Breakdown of academic impact, for papers by Sam Loveless Breakdown of academic impact, for papers by Patrick Peschl Breakdown of academic impact, for papers by Alessandra Mattioda Breakdown of academic impact, for papers by De‐Hyung Lee
Rankless by CCL
2026